[1]. Xu, X.; Ong, Y. K.; Wang, Y., Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines. Mil Med Res 2020, 7 (1), 22.
[2]. Zhu, L.; She, Z. G.; Cheng, X.; Qin, J. J.; Zhang, X. J.; Cai, J.; Lei, F.; Wang, H.; Xie, J.; Wang, W.; Li, H.; Zhang, P.; Song, X.; Chen, X.; Xiang, M.; Zhang, C.; Bai, L.; Xiang, D.; Chen, M. M.; Liu, Y.; Yan, Y.; Liu, M.; Mao, W.; Zou, J.; Liu, L.; Chen, G.; Luo, P.; Xiao, B.; Zhang, C.; Zhang, Z.; Lu, Z.; Wang, J.; Lu, H.; Xia, X.; Wang, D.; Liao, X.; Peng, G.; Ye, P.; Yang, J.; Yuan, Y.; Huang, X.; Guo, J.; Zhang, B. H.; Li, H., Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab 2020, 31 (6), 1068-1077 e3.
[3]. Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; Guan, L.; Wei, Y.; Li, H.; Wu, X.; Xu, J.; Tu, S.; Zhang, Y.; Chen, H.; Cao, B., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020, 395 (10229), 1054-1062.
[4]. Wu, C.; Chen, X.; Cai, Y.; Xia, J.; Zhou, X.; Xu, S.; Huang, H.; Zhang, L.; Zhou, X.; Du, C.; Zhang, Y.; Song, J.; Wang, S.; Chao, Y.; Yang, Z.; Xu, J.; Zhou, X.; Chen, D.; Xiong, W.; Xu, L.; Zhou, F.; Jiang, J.; Bai, C.; Zheng, J.; Song, Y., Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020, 180 (7), 934-943.
[5]. Matthay, M. A.; Aldrich, J. M.; Gotts, J. E., Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med 2020, 8 (5), 433-434.
[6]. Ji, H. L.; Zhao, R.; Matalon, S.; Matthay, M. A., Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Physiol Rev 2020, 100 (3), 1065-1075.
[7]. Yan, Y.; Yang, Y.; Wang, F.; Ren, H.; Zhang, S.; Shi, X.; Yu, X.; Dong, K., Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care 2020, 8 (7).
[8]. Chobanian, A. V.; Bakris, G. L.; Black, H. R.; Cushman, W. C.; Green, L. A.; Izzo, J. L., Jr.; Jones, D. W.; Materson, B. J.; Oparil, S.; Wright, J. T., Jr.; Roccella, E. J., Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42 (6), 1206-52.
[9]. Thompson, B. T.; Chambers, R. C.; Liu, K. D., Acute Respiratory Distress Syndrome. N Engl J Med 2017, 377 (6), 562-572.
[10]. Khwaja, A., KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012, 120 (4), c179-84.
[11]. National Health Commission SAoTCM. Diagnosis and treatment of COVID-19 (trial version 7). http://www.gov.cn/zhengce/zhengceku/2020-03/04/content_5486705.htm. Accessed 3 Mar 2020.
[12]. Hussain, A.; Ali, I.; Hassan, Z., People with Diabetes Mellitus: Soft target for COVID-19 infection. Pak J Med Sci 2020, 36 (COVID19-S4), S3-S5.
[13]. Guo, W.; Li, M.; Dong, Y.; Zhou, H.; Zhang, Z.; Tian, C.; Qin, R.; Wang, H.; Shen, Y.; Du, K.; Zhao, L.; Fan, H.; Luo, S.; Hu, D., Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020, e3319.
[14]. Shi, Q.; Zhang, X.; Jiang, F.; Zhang, X.; Hu, N.; Bimu, C.; Feng, J.; Yan, S.; Guan, Y.; Xu, D.; He, G.; Chen, C.; Xiong, X.; Liu, L.; Li, H.; Tao, J.; Peng, Z.; Wang, W., Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care 2020, 43 (7), 1382-1391.
[15]. Bornstein, S. R.; Rubino, F.; Khunti, K.; Mingrone, G.; Hopkins, D.; Birkenfeld, A. L.; Boehm, B.; Amiel, S.; Holt, R. I.; Skyler, J. S.; DeVries, J. H.; Renard, E.; Eckel, R. H.; Zimmet, P.; Alberti, K. G.; Vidal, J.; Geloneze, B.; Chan, J. C.; Ji, L.; Ludwig, B., Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020, 8 (6), 546-550.
[16]. Shi, S.; Qin, M.; Cai, Y.; Liu, T.; Shen, B.; Yang, F.; Cao, S.; Liu, X.; Xiang, Y.; Zhao, Q.; Huang, H.; Yang, B.; Huang, C., Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J 2020, 41 (22), 2070-2079.
[17]. Sjöholm, A.; Nyström, T., Endothelial inflammation in insulin resistance. Lancet 2005, 365 (9459), 610-2.
[18]. Festa, A.; D'Agostino, R., Jr.; Howard, G.; Mykkänen, L.; Tracy, R. P.; Haffner, S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102 (1), 42-7.
[19]. Feng, Q.; Zhou, H.; Zhang, X.; Liu, X.; Wang, J.; Zhang, C.; Ma, X.; Quan, C.; Zheng, Z., Acarbose, as a potential drug, effectively blocked the dynamic metastasis of EV71 from the intestine to the whole body. Infect Genet Evol 2020, 81, 104210.
[20]. Dang, M.; Wang, X.; Wang, Q.; Wang, Y.; Lin, J.; Sun, Y.; Li, X.; Zhang, L.; Lou, Z.; Wang, J.; Rao, Z., Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell 2014, 5 (9), 692-703.
[21]. Zhou, P.; Yang, X. L.; Wang, X. G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H. R.; Zhu, Y.; Li, B.; Huang, C. L.; Chen, H. D.; Chen, J.; Luo, Y.; Guo, H.; Jiang, R. D.; Liu, M. Q.; Chen, Y.; Shen, X. R.; Wang, X.; Zheng, X. S.; Zhao, K.; Chen, Q. J.; Deng, F.; Liu, L. L.; Yan, B.; Zhan, F. X.; Wang, Y. Y.; Xiao, G. F.; Shi, Z. L., A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579 (7798), 270-273.
[22]. Yan, R.; Zhang, Y.; Li, Y.; Xia, L.; Guo, Y.; Zhou, Q., Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020, 367 (6485), 1444-1448.
[23]. Watanabe, Y.; Allen, J. D.; Wrapp, D.; McLellan, J. S.; Crispin, M., Site-specific glycan analysis of the SARS-CoV-2 spike. Science 2020, 369 (6501), 330-333.
[24]. Alifano, M.; Alifano, P.; Forgez, P.; Iannelli, A., Renin-angiotensin system at the heart of COVID-19 pandemic. Biochimie 2020, 174, 30-33.
[25]. Gu, Y.; Wang, X.; Li, J.; Zhang, Y.; Zhong, H.; Liu, R.; Zhang, D.; Feng, Q.; Xie, X.; Hong, J.; Ren, H.; Liu, W.; Ma, J.; Su, Q.; Zhang, H.; Yang, J.; Wang, X.; Zhao, X.; Gu, W.; Bi, Y.; Peng, Y.; Xu, X.; Xia, H.; Li, F.; Xu, X.; Yang, H.; Xu, G.; Madsen, L.; Kristiansen, K.; Ning, G.; Wang, W., Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat Commun 2017, 8 (1), 1785.
[26]. Zuo, T.; Zhang, F.; Lui, G. C. Y.; Yeoh, Y. K.; Li, A. Y. L.; Zhan, H.; Wan, Y.; Chung, A. C. K.; Cheung, C. P.; Chen, N.; Lai, C. K. C.; Chen, Z.; Tso, E. Y. K.; Fung, K. S. C.; Chan, V.; Ling, L.; Joynt, G.; Hui, D. S. C.; Chan, F. K. L.; Chan, P. K. S.; Ng, S. C., Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology 2020, 159 (3), 944-955 e8.
[27]. Au Yeung, S. L.; Luo, S.; Schooling, C. M., The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study. Diabetologia 2019, 62 (9), 1638-1646.
[28]. Zhang, J.; Dong, J.; Martin, M.; He, M.; Gongol, B.; Marin, T. L.; Chen, L.; Shi, X.; Yin, Y.; Shang, F.; Wu, Y.; Huang, H. Y.; Zhang, J.; Zhang, Y.; Kang, J.; Moya, E. A.; Huang, H. D.; Powell, F. L.; Chen, Z.; Thistlethwaite, P. A.; Yuan, Z. Y.; Shyy, J. Y., AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension. Am J Respir Crit Care Med 2018, 198 (4), 509-520.